In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs
Twostage fermentation optimization for poly3hydroxybutyrate production from methanol by a new Methylobacterium isolate from oil fields
Gut microbiotaderived short-chain fatty acids promote prostate cancer growth via IGF1 signaling
GLP-1 receptor blockade increased postprandial glucagon in both surgical groups
Document your cancellation request with dates and screenshots to protect yourself